(0.08%) 5 521.50 points
(0.11%) 39 889 points
(0.20%) 19 791 points
(0.02%) $81.65
(0.43%) $2.82
(-0.31%) $2 337.20
(0.07%) $29.55
(0.20%) $1 003.80
(0.04%) $0.932
(0.03%) $10.54
(0.02%) $0.788
(-0.85%) $87.25
3.55% $ 1.750
Live Chart Being Loaded With Signals
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes...
Stats | |
---|---|
Dzisiejszy wolumen | 376 883 |
Średni wolumen | 190 714 |
Kapitalizacja rynkowa | 42.97M |
EPS | $-0.680 ( Q1 | 2024-05-08 ) |
Następna data zysków | ( $0 ) 2024-08-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.690 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0120 (0.69%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-12 | Aghazadeh Behzad | Buy | 45 832 | Stock Option (right to buy) |
2024-06-12 | Maroun Richard E | Buy | 45 832 | Stock Option (right to buy) |
2024-06-12 | Hirmand Mohammad | Buy | 45 832 | Stock Option (right to buy) |
2024-06-12 | Reeve Emma | Buy | 45 832 | Stock Option (right to buy) |
2024-06-12 | Castelein Caley | Buy | 45 832 | Stock Option (right to buy) |
INSIDER POWER |
---|
46.82 |
Last 98 transactions |
Buy: 5 197 015 | Sell: 1 085 050 |
Wolumen Korelacja
Aadi Bioscience, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
OZEM | 1 |
EVCGX | 0.885 |
BUJA | 0.879 |
NBBK | 0.874 |
BDGS | 0.868 |
MCHFX | 0.861 |
MICFX | 0.861 |
MSAQX | 0.861 |
AITR | 0.858 |
FHKCX | 0.858 |
10 Najbardziej negatywne korelacje | |
---|---|
BRLSW | -0.864 |
PTLO | -0.863 |
CLMB | -0.858 |
IIMFX | -0.855 |
RDZN | -0.853 |
APLM | -0.851 |
RENB | -0.846 |
FATBB | -0.841 |
BTCT | -0.836 |
NAAS | -0.835 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Aadi Bioscience, Inc. Korelacja - Waluta/Towar
Aadi Bioscience, Inc. Finanse
Annual | 2023 |
Przychody: | $24.35M |
Zysk brutto: | $21.55M (88.47 %) |
EPS: | $-2.44 |
FY | 2023 |
Przychody: | $24.35M |
Zysk brutto: | $21.55M (88.47 %) |
EPS: | $-2.44 |
FY | 2022 |
Przychody: | $15.22M |
Zysk brutto: | $13.88M (91.23 %) |
EPS: | $-2.53 |
FY | 2021 |
Przychody: | $1.00M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-12.41 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Aadi Bioscience, Inc.
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej